GAPDH and gastric cancer: In advanced gastric cancer (pathologic stages III and IV) patients, the post-operative expression levels of PPL/GAPDH, miR140-5p/miR197, and miR301a/miR197 were significantly increased compared with the pre-operative levels (Table 6).